Accenture CEO Julie Sweet has been diagnosed with early-stage breast cancer. With an excellent prognosis and a curable ...

Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff ...

Nonetheless, the CEO of the world’s largest IT company will lead its day-to-day operations throughout the process.

Today, Accenture plc (NYSE:ACN), a $243 billion market cap technology consulting giant, disclosed an update on the health of Julie Sweet, the company's Chair and Chief Executive Officer.

However, the CEO will continue to look after the day-to-day operations of the IT services and consulting firm during the ...

Accenture CEO Julie Sweet was praised this week for her openness regarding a breast cancer diagnosis, which also gave rare ...

Plus: All the news and watercooler chat from Fortune. Good morning. Accenture CEO Julie Sweet announced yesterday that her breast cancer has come back, noting in a memo to staff that “the prognosis ...

Accenture scraps diversity goals amid U.S. political changes, following other tech giants, impacting DEI programs and ...

CEO Julie Sweet said the company would end its employee diversity representation goals and put “a greater focus on inclusion ...